Sandoz incorporates RFID technology on injectables 20-Oct-2020 By Jenni Spinner The generic drug manufacturer is working with Kit Check to incorporate the company's drug supply-chain management technology into two of its products.
CPhI Festival of Pharma CPhI: Dramatic changes ahead for the generics market 12-Oct-2020 By Jenni Spinner Technology impacting generic drugs include artificial intelligence, telemedicine, fraud-preventing digital solutions and more, according to a report
TFF, Union Therapeutics join on potential COVID-19 treatment 27-Aug-2020 By Jenni Spinner The companies will partner on developing dry-powder forms of niclosamide as a treatment for the virus, using thin-film freezing technology.
Webinar delves into drug delivery innovations 09-Jul-2020 By Jenni Spinner Innovations in Drug Delivery Part II, a free online event on July 15, will feature novel technologies and innovative solutions to current challenges.
Takeda taps Evox for exosome therapeutics 30-Mar-2020 By Ben Hargreaves The partners will focus on developing five potential exosome treatment for rare diseases.
Formulation method improves bioavailability of poorly soluble molecules 09-Mar-2020 By Vassia Barba Orion to benefit from Nanoform’s formulation technology, which is able to improve bioavailability and solubility of early-stage compounds.
FDA approves biodegradable implant for eye conditions 09-Mar-2020 By Ben Hargreaves Allergan’s intracameral sustained-release implant receives US FDA approval for two indications treating ophthalmic conditions.
Merck KGaA partners on 3D-printed tablets manufacture 27-Feb-2020 By Vassia Barba Merck to produce 3D-printed tablets by tapping into the technology developed by AMCM, making a move towards digitalization.
Formulation technology improving CBD uptake bought out 20-Feb-2020 By Vassia Barba Bioavailability of water insoluble compounds, such as CBD, enhanced up to 15 times with the technology of Solmic, leading to its acquisition by Betterlife.
Patient confidence key in switching delivery of biosimilars 05-Feb-2020 By Ben Hargreaves As developers of biosimilars look at ways of differentiating from originator products, experts warn that patients will need to be brought on board.
RaniPill passes Phase I test for orally delivered biologics 05-Feb-2020 By Ben Hargreaves Rani Therapeutics releases positive results from a Phase I clinical study into delivering octreotide by RaniPill.
Partnership aims to identify over 8,000 antibiotic-resistant pathogens 30-Jan-2020 By Vassia Barba Noscendo builds on its diagnostic platform to enable identification of antibiotic resistant microorganisms, in partnership with German hospital.
Prices of nearly 500 drugs increased in 2020 08-Jan-2020 By Vassia Barba Nearly 500 prescription drugs will become more costly in 2020, as drugmakers proceed with prices increases averaging 5%, 3 Axis Advisors says.
Asahi Kasei in $1.3bn bid to access US pharma market 28-Nov-2019 By Ben Hargreaves Asahi Kasei has a bid accepted for oral dose specialist, Veloxis, with one eye on gaining a position in the US market.
Zosano readies contract manufacturers for pre-approval inspections 25-Nov-2019 By Nick Taylor Zosano Pharma prepares contract manufacturers to host pre-approval inspections to support filing for approval of migraine drug.
